
Please try another search
Sailong Pharmaceutical Group Co Ltd, formerly Zhuhai Sailong Pharmaceutical Co Ltd, is a China-based company principally engaged in the research and development, production and sales of pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and preparations, as well as providing technical services. The Company’s main products include monosialin tetrahexose ganglioside sodium injections, brain protein hydrolyzate for injections, clindamycin phosphate for injections, pantoprazole sodium for injections and milrinon injections, among others. Through its subsidiaries, the Company is also engaged in the sales of scraps, provision of technical services and sales promotion. The Company mainly conducts its businesses with domestic market.
Name | Age | Since | Title |
---|---|---|---|
Haibo Huang | 44 | 2023 | Supervisor |
Jian Feng Li | 43 | 2015 | Deputy GM & Director |
Nangui Cai | 62 | 2014 | Chairman & CEO |
Yongjun Deng | 52 | 2017 | Non-Independent Director |
Chuanyun Pan | 50 | 2021 | Independent Director |
Bei Zhou | 55 | 2014 | Non-Employee Chairman of the Supervisory Board |
Dawen Liu | 36 | 2014 | Deputy GM & Non-Independent Director |
Xiaoxin Chen | 47 | 2021 | Independent Director |
Gongfen Li | 70 | 2023 | Independent Director |
Zhang Xu | 39 | 2017 | Board Secretary, Deputy GM & Director |
Lin Tang | 52 | 2014 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review